In 2017, around 1.7 million people in the United States were suffering from Opioid Use Disorder (OUD). More than 47,000 of those Americans died as a result of OUD¹. Community pharmacist are in an ideal position to impact this number by intervening and decreasing a patient’s risk of developing OUD.

NCPA is dedicated to providing pharmacists with the tools and resources needed to care for all patients taking opioids and ensure the safety of their communities. Explore this collection of resources on how best to accomplish this vital task. 

1. Center for Behavioral Health Statistics and Quality (CBHSQ). 2017 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.

The Pharmacy Access to Resources and Medication for Opioid Use Disorder (PhARM-OUD) Guideline

This guideline is designed to educate pharmacists about the importance of providing access to buprenorphine and help them navigate a complex set of regulatory and clinical barriers to access. Read more. 

• Background

• Pharmacist's Role

• Prevention

• Naloxone

• Treatment

• Legislative Updates